
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14145911
[patent_doc_number] => 10253319
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => miRNA modulators of thermogenesis
[patent_app_type] => utility
[patent_app_number] => 15/790302
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 28
[patent_no_of_words] => 34833
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15790302
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/790302 | miRNA modulators of thermogenesis | Oct 22, 2017 | Issued |
Array
(
[id] => 12160305
[patent_doc_number] => 20180031571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'METHOD FOR DIAGNOSING A MOLECULAR PHENOTYPE OF A PATIENT SUFFERING FROM AN ILLNESS ACCOMPANIED BY CHRONIC INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 15/782595
[patent_app_country] => US
[patent_app_date] => 2017-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11120
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15782595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/782595 | Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation | Oct 11, 2017 | Issued |
Array
(
[id] => 12177494
[patent_doc_number] => 20180036430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'THERAPEUTIC MIRNAS FOR TREATING HEART AND SKELETAL MUSCLE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/730460
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17191
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15730460
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/730460 | Therapeutic miRNAs for treating heart and skeletal muscle diseases | Oct 10, 2017 | Issued |
Array
(
[id] => 12770665
[patent_doc_number] => 20180148723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => CHEMICAL MODIFICATION OF SHORT SMALL HAIRPIN RNAS FOR INHIBITION OF GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 15/725870
[patent_app_country] => US
[patent_app_date] => 2017-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15725870
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/725870 | Chemical modification of short small hairpin RNAs for inhibition of gene expression | Oct 4, 2017 | Issued |
Array
(
[id] => 12904897
[patent_doc_number] => 20180193474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => Gene/carrier complex for preventing or treating inflammatory diseases
[patent_app_type] => utility
[patent_app_number] => 15/721199
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721199
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721199 | Gene/carrier complex for preventing or treating inflammatory diseases | Sep 28, 2017 | Abandoned |
Array
(
[id] => 12681937
[patent_doc_number] => 20180119145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => COMPOUNDS AND METHODS FOR REDUCING TAU EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 15/721366
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721366
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721366 | Compounds and methods for reducing Tau expression | Sep 28, 2017 | Issued |
Array
(
[id] => 15035525
[patent_doc_number] => 20190328767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => Use Of Polyinosinic-polycytidylic Acid Compositions In Treatment Of Malignant Effusion
[patent_app_type] => utility
[patent_app_number] => 16/463275
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16463275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/463275 | Use of polyinosinic-polycytidylic acid compositions in treatment of malignant effusion | Sep 25, 2017 | Issued |
Array
(
[id] => 12137033
[patent_doc_number] => 20180015117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'METHOD FOR PREVENTION OF COLECTOMY'
[patent_app_type] => utility
[patent_app_number] => 15/711228
[patent_app_country] => US
[patent_app_date] => 2017-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9871
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15711228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/711228 | METHOD FOR PREVENTION OF COLECTOMY | Sep 20, 2017 | Abandoned |
Array
(
[id] => 12702133
[patent_doc_number] => 20180125877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => IMMUNE MODULATION WITH TLR9 AGONISTS FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 15/705631
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7115
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705631 | Immune modulation with TLR9 agonists for cancer treatment | Sep 14, 2017 | Issued |
Array
(
[id] => 12240166
[patent_doc_number] => 20180073029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-15
[patent_title] => 'HIGH-EFFICIENCY TRANSFECTION OF BIOLOGICAL CELLS USING SONOPORATION'
[patent_app_type] => utility
[patent_app_number] => 15/706524
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16738
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15706524
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/706524 | High-efficiency transfection of biological cells using sonoporation | Sep 14, 2017 | Issued |
Array
(
[id] => 12119111
[patent_doc_number] => 20180002697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/705172
[patent_app_country] => US
[patent_app_date] => 2017-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20716
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15705172
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/705172 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Sep 13, 2017 | Issued |
Array
(
[id] => 14685531
[patent_doc_number] => 20190241880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => PROXIMITY-DEPENDENT BIOTINYLATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/333185
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333185
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333185 | Proximity-dependent biotinylation and uses thereof | Sep 12, 2017 | Issued |
Array
(
[id] => 12178959
[patent_doc_number] => 20180037895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 15/701921
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21434
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15701921
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/701921 | COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES | Sep 11, 2017 | Abandoned |
Array
(
[id] => 16771187
[patent_doc_number] => 10982282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => MicroRNAs as biomarkers for endometriosis
[patent_app_type] => utility
[patent_app_number] => 16/329436
[patent_app_country] => US
[patent_app_date] => 2017-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25899
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16329436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/329436 | MicroRNAs as biomarkers for endometriosis | Aug 29, 2017 | Issued |
Array
(
[id] => 12185743
[patent_doc_number] => 20180044676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 15/687306
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86905
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15687306
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/687306 | Compositions and methods for modulating TTR expression | Aug 24, 2017 | Issued |
Array
(
[id] => 12641943
[patent_doc_number] => 20180105812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/684902
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684902
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684902 | Short interfering nucleic acid (siNA) compositions | Aug 22, 2017 | Issued |
Array
(
[id] => 13690085
[patent_doc_number] => 20170355997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS
[patent_app_type] => utility
[patent_app_number] => 15/682104
[patent_app_country] => US
[patent_app_date] => 2017-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15682104
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/682104 | METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING PRURITIS | Aug 20, 2017 | Abandoned |
Array
(
[id] => 14454587
[patent_doc_number] => 10323246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-18
[patent_title] => Interfering RNA molecules
[patent_app_type] => utility
[patent_app_number] => 15/678024
[patent_app_country] => US
[patent_app_date] => 2017-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 48
[patent_no_of_words] => 18556
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15678024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/678024 | Interfering RNA molecules | Aug 14, 2017 | Issued |
Array
(
[id] => 12814105
[patent_doc_number] => 20180163205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/673019
[patent_app_country] => US
[patent_app_date] => 2017-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15673019
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/673019 | ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF | Aug 8, 2017 | Abandoned |
Array
(
[id] => 12231886
[patent_doc_number] => 20180064749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'CONJUGATION OF LIPOPHILIC ALBUMIN-BINDING MOIETY TO RNA FOR IMPROVED CARRIER-FREE IN VIVO PHARMACOKINETICS AND GENE SILENCING'
[patent_app_type] => utility
[patent_app_number] => 15/671131
[patent_app_country] => US
[patent_app_date] => 2017-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 13461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671131
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/671131 | Conjugation of lipophilic albumin-binding moiety to RNA for improved carrier-free in vivo pharmacokinetics and gene silencing | Aug 6, 2017 | Issued |